Filed: 8/14/2026ACC: 0001420506-26-001799
📋 What this filing means
PROSIGHT MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 36 equity positions with a total reported market value of $580.35M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
36
Positions
$580.35M
Total AUM (reported)
34.80M
Total Shares
Allocation by class
COM$329.11M56.7%
COM NEW$76.22M13.1%
SPON ADR$61.26M10.6%
COM PAR $.01$40.05M6.9%
SHS$29.04M5.0%
CL A COM$18.85M3.2%
SPONSORED ADS$14.31M2.5%
Portfolio Concentration
Top 3$176.24M30.4%
4–10$234.21M40.4%
11–25$151.26M26.1%
Rest$18.64M3.2%
Top 3 weight
30.4%
Top 10 weight
70.7%
Voting Authority Distribution
Total shares with voting rights: 34.80M
Sole
Full voting authority
34.80M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole36
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings36
Rows:
LAKEFRONT BIOTHERAPEUTICS NV
SOLEShares2.04M
TypeSH
Market value$61.26M
10.56%
Sole
2.04M
Shared
0.00
None
0.00
JANUX THERAPEUTICS INC
SOLEShares3.80M
TypeSH
Market value$58.44M
10.07%
Sole
3.80M
Shared
0.00
None
0.00
NEKTAR THERAPEUTICS
SOLEShares810K
TypeSH
Market value$56.55M
9.74%
Sole
810K
Shared
0.00
None
0.00
BOSTON SCIENTIFIC CORP
SOLEShares1.27M
TypeSH
Market value$54.22M
9.34%
Sole
1.27M
Shared
0.00
None
0.00
SHATTUCK LABS INC
SOLEShares5.96M
TypeSH
Market value$41.35M
7.12%
Sole
5.96M
Shared
0.00
None
0.00
INSMED INC
SOLEShares375.61K
TypeSH
Market value$40.05M
6.90%
Sole
375.61K
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares98.08K
TypeSH
Market value$29.53M
5.09%
Sole
98.08K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares1.20M
TypeSH
Market value$26.23M
4.52%
Sole
1.20M
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares2.02M
TypeSH
Market value$22.18M
3.82%
Sole
2.02M
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares394.39K
TypeSH
Market value$20.66M
3.56%
Sole
394.39K
Shared
0.00
None
0.00
IRHYTHM HOLDINGS INC
SOLEShares165.50K
TypeSH
Market value$19.69M
3.39%
Sole
165.50K
Shared
0.00
None
0.00
VEEVA SYS INC
SOLEShares106.20K
TypeSH
Market value$18.85M
3.25%
Sole
106.20K
Shared
0.00
None
0.00
ZYMEWORKS INC
SOLEShares674.43K
TypeSH
Market value$17.63M
3.04%
Sole
674.43K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares107.39K
TypeSH
Market value$14.31M
2.47%
Sole
107.39K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares374.67K
TypeSH
Market value$14.02M
2.42%
Sole
374.67K
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
SOLEShares449.80K
TypeSH
Market value$12.14M
2.09%
Sole
449.80K
Shared
0.00
None
0.00
ADC THERAPEUTICS SA
SOLEShares7.82M
TypeSH
Market value$8.37M
1.44%
Sole
7.82M
Shared
0.00
None
0.00
ICU MED INC
SOLEShares51K
TypeSH
Market value$7.48M
1.29%
Sole
51K
Shared
0.00
None
0.00
INTUITIVE SURGICAL INC
SOLEShares17K
TypeSH
Market value$6.76M
1.16%
Sole
17K
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
SOLEShares650K
TypeSH
Market value$6.10M
1.05%
Sole
650K
Shared
0.00
None
0.00
PROCEPT BIOROBOTICS CORP
SOLEShares268.27K
TypeSH
Market value$6.06M
1.04%
Sole
268.27K
Shared
0.00
None
0.00
GENEDX HOLDINGS CORP
SOLEShares85.50K
TypeSH
Market value$5.87M
1.01%
Sole
85.50K
Shared
0.00
None
0.00
OPTION CARE HEALTH INC
SOLEShares270.72K
TypeSH
Market value$5.68M
0.98%
Sole
270.72K
Shared
0.00
None
0.00
ONKURE THERAPEUTICS INC
SOLEShares978.99K
TypeSH
Market value$4.46M
0.77%
Sole
978.99K
Shared
0.00
None
0.00
EMERGENT BIOSOLUTIONS INC
SOLEShares459.95K
TypeSH
Market value$3.85M
0.66%
Sole
459.95K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
LAKEFRONT BIOTHERAPEUTICS NVSOLE | SPON ADR | 2.04M | SH | $61.26M 10.56% | 2.04M | 0.00 | 0.00 |
JANUX THERAPEUTICS INCSOLE | COM | 3.80M | SH | $58.44M 10.07% | 3.80M | 0.00 | 0.00 |
NEKTAR THERAPEUTICSSOLE | COM NEW | 810K | SH | $56.55M 9.74% | 810K | 0.00 | 0.00 |
BOSTON SCIENTIFIC CORPSOLE | COM | 1.27M | SH | $54.22M 9.34% | 1.27M | 0.00 | 0.00 |
SHATTUCK LABS INCSOLE | COM | 5.96M | SH | $41.35M 7.12% | 5.96M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 375.61K | SH | $40.05M 6.90% | 375.61K | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 98.08K | SH | $29.53M 5.09% | 98.08K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 1.20M | SH | $26.23M 4.52% | 1.20M | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 2.02M | SH | $22.18M 3.82% | 2.02M | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 394.39K | SH | $20.66M 3.56% | 394.39K | 0.00 | 0.00 |
IRHYTHM HOLDINGS INCSOLE | COM | 165.50K | SH | $19.69M 3.39% | 165.50K | 0.00 | 0.00 |
VEEVA SYS INCSOLE | CL A COM | 106.20K | SH | $18.85M 3.25% | 106.20K | 0.00 | 0.00 |
ZYMEWORKS INCSOLE | COM | 674.43K | SH | $17.63M 3.04% | 674.43K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 107.39K | SH | $14.31M 2.47% | 107.39K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 374.67K | SH | $14.02M 2.42% | 374.67K | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCSOLE | COM | 449.80K | SH | $12.14M 2.09% | 449.80K | 0.00 | 0.00 |
ADC THERAPEUTICS SASOLE | SHS | 7.82M | SH | $8.37M 1.44% | 7.82M | 0.00 | 0.00 |
ICU MED INCSOLE | COM | 51K | SH | $7.48M 1.29% | 51K | 0.00 | 0.00 |
INTUITIVE SURGICAL INCSOLE | COM NEW | 17K | SH | $6.76M 1.16% | 17K | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSSOLE | COM NEW | 650K | SH | $6.10M 1.05% | 650K | 0.00 | 0.00 |
PROCEPT BIOROBOTICS CORPSOLE | COM | 268.27K | SH | $6.06M 1.04% | 268.27K | 0.00 | 0.00 |
GENEDX HOLDINGS CORPSOLE | COM CL A | 85.50K | SH | $5.87M 1.01% | 85.50K | 0.00 | 0.00 |
OPTION CARE HEALTH INCSOLE | COM NEW | 270.72K | SH | $5.68M 0.98% | 270.72K | 0.00 | 0.00 |
ONKURE THERAPEUTICS INCSOLE | COM CL A | 978.99K | SH | $4.46M 0.77% | 978.99K | 0.00 | 0.00 |
EMERGENT BIOSOLUTIONS INCSOLE | COM | 459.95K | SH | $3.85M 0.66% | 459.95K | 0.00 | 0.00 |
Page 1 of 2